Fundraising Fox
Factor Bioscience
Cambridge, US · Delaware LLC
Find your way into Factor Bioscience
Sign up to see every warm intro you have to Factor Bioscience
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Factor Bioscience team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Factor Bioscience develops mRNA, gene-editing, and cell-reprogramming technologies for cell engineering, including tools to repair disease-causing mutations and engineer immune cells to fight cancer. It works with strategic pharmaceutical and biotech partners across product development stages, from target identification through cell line development and manufacturing in its cleanrooms.
Founders & leadership
MA
Matt AngelCo-Founder, Chairman and CEOMatt Angel is co-founder, chairman, and CEO of Factor Bioscience, which develops mRNA, gene-editing, and cell-reprogramming technologies for cell engineering and therapeutic applications including cancer immunotherapy.
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2025
▶$1MraisedSep 2025 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedSep 2025 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew AngelExecutive Officer, Director
- Christopher RohdeDirector
- Offering amount
- $5M
- Amount sold
- $1M
- First sale
- Sep 2025
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
Twist BioscienceTwist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals. The platform enables faster and more affordable DNA synthesis at scale with customizable high-throughput capabilities.
Generate BiomedicinesGenerate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering. The company creates new drugs on demand across diverse biologic modalities for immunology, oncology, infectious disease, and vaccines.
Life BiosciencesLife Biosciences is a biopharmaceutical company developing therapies focused on aging and age-related diseases, working across gene therapy and neuroscience programs. It advances drug candidates from discovery through clinical development.
Transition BioTransition Bio applies methods from physics, chemistry, biology, and machine learning to study protein biophysics—including protein aggregation, self-assembly, and protein-protein interactions—for developing therapeutics targeting health and disease. The company is a platform-based biotherapeutics developer founded on academic research from the University of Cambridge.
Precision BioSciencesPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).
Companies working in the same space as Factor Bioscience.
Frequently asked questions
- What does Factor Bioscience do?
- Factor Bioscience develops mRNA, gene-editing, and cell-reprogramming technologies for cell engineering, including tools to repair disease-causing mutations and engineer immune cells to fight cancer. It works with strategic pharmaceutical and biotech partners across product development stages, from target identification through cell line development and manufacturing in its cleanrooms.
- Who founded Factor Bioscience?
- Factor Bioscience was founded by Christopher Rohde, Matt Angel.
- How much funding has Factor Bioscience raised?
- Factor Bioscience has disclosed $1M raised across 1 round.
- Where is Factor Bioscience headquartered?
- Factor Bioscience is headquartered in Cambridge, US.